TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending – Hagens Berman

SAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against the medical technology company, which specializes in organ transplant therapy, alleging that the company and certain executives engaged in fraudulent practices and concealed safety issues. The suit, captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), represents investors who purchased or acquired TransMedics Group, Inc. (NASDAQ: TMDX) securities between February 28, 2023, and January 10, 2025. ...